FDA approves Purdue Pharma’s Palladone

Share this content:
The FDA has approved Purdue Pharma's Palladone (hydromorphone
hydrochloride) capsules for the management of persistent moderate
to severe pain in patients requiring continuous opioid pain
relief for an extended period of time.
Share this content:
Scroll down to see the next article